drugset / Trial / NCT00958334
Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003
Non-randomizedSingle-groupOpen-labelTreatment
Summary
ZPU-003 EXT is a 2-year extension study of ZPU-003 (NCT00882258) to determine the continued safety and efficacy of Proellex in women who have previously completed the double-blind portion of the study.
Timeline
- Start
- 2006-09-07
- Primary completion
- 2008-10-15
- Completion
- 2008-10-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Telapristone Acetate | Other / unclassified | 12.5 mg | — |
| Subject | Telapristone Acetate | Other / unclassified | 25 mg | — |